Correlates of cannabis use in a sample of mental health treatment-seeking Canadian armed forces members and veterans

• Published in: BMC psychiatry 2023-11, Vol.23 (1), p.836-836, Article 836
• Main Authors: St Cyr, Kate, Nazarov, Anthony, Le, Tri, Nouri, Maede, Saha, Priyonto, Forchuk, Callista A, Soares, Vanessa, Wanklyn, Sonya G, Bird, Brian M, Davis, Brent D, King, Lisa, Ketcheson, Felicia, Richardson, J Don
• Format: Article
• Language: English
• Subjects: Alcohol use; Armed Forces; Cannabis; Cross-Sectional Studies; Evidence-based medicine; Humans; Marijuana; Medical marijuana; Mental disorders; Mental Health; Military personnel; Military Personnel - psychology; Ontario - epidemiology; Post traumatic stress disorder; Psychiatric services; Psychiatry; Psychotherapy; Questionnaires; Self report; Sleep; Statistical analysis; Stress Disorders, Post-Traumatic - psychology; Suicide; Symptom management; Veterans; Veterans - psychology
• ISSN: 1471-244X; 1471-244X
• DOI: 10.1186/s12888-023-05237-2

Canadian Armed Forces (CAF) members and Veterans are more likely to experience mental health (MH) conditions, such as posttraumatic stress disorder (PTSD), than the general Canadian population. Previous research suggests that an increasing number of individuals are employing cannabis for MH symptom relief, despite a lack of robust evidence for its effectiveness in treating PTSD. This research aimed to: (1) describe the prevalence of current cannabis use among MH treatment-seeking CAF members and Veterans; and (2) estimate the association between current cannabis use and a number of sociodemographic, military, and MH-related characteristics. Using cross-sectional intake data from 415 CAF members and Veterans attending a specialized outpatient MH clinic in Ontario, Canada, between January 2018 and December 2020, we estimated the proportion of CAF members and Veterans who reported current cannabis use for either medical or recreational purposes. We used multivariable logistic regression to estimate adjusted odds ratios for a number of sociodemographic, military, and MH-related variables and current cannabis use. Almost half of the study participants (n = 187; 45.1%) reported current cannabis use. Respondents who reported current cannabis use for medical purposes had a higher median daily dose than those who reported current cannabis use for recreational purposes. The multivariable logistic regression identified younger age, lower income, potentially hazardous alcohol use, and increased bodily pain as statistically significant correlates of current cannabis use among our MH treatment-seeking sample. PTSD severity, depressive severity, sleep quality, and suicide ideation were not statistically associated with current cannabis use. Almost half of our treatment-seeking sample reported current cannabis use for medical or recreational purposes, emphasizing the importance of screening MH treatment-seeking military members and Veterans for cannabis use prior to commencing treatment. Future research building upon this study could explore the potential impact of cannabis use on MH outcomes.